MicroPort MedBot serves up inaugural profit on booming exports
The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the first half of 2026, reversing years of losses Key Takeaways: MicroPort…
Venus Medtech still seeking cure for governance problems
The transcatheter maker’s shares were suspended last November, and it must still meet several conditions from the Hong Kong Stock Exchange before trading can resume Key Takeways: Venus Medtech disclosed…
Cash-Strapped Cryofocus Medtech Scrambles to Raise Funds With IPO
With only 128 million yuan in cash left in its coffers, the maker of innovative medical devices is desperate to secure fresh capital with a second stab at a Hong…
Medical Device Maker Venus Medtech Pumps Up Investors With Prospect of 2021 Profits
Company funds expansion through $400 million share sale as it targets U.S. and EU with growing pipeline of heart valve-replacement products Major Takeaways Venus Medtech’s recent $400 million equity fundraising…
Recent Articles
RELATED ARTICLES
-
Ubtech charms investors with companion robots – until reality sinks in
- Tiny income, big dreams: can True Health become the next robotics champion?
- INTERVIEW: Cainiao rolls out ZeeBot in latest step toward ‘Dark Warehouses’
- The new smart home: Where robots handle chores and provide companionship
-
Razor-thin margins slice holes in Leapmotor’s inaugural profit
9863.HK
- Dobot taps Shenzhen market to fund its bet on humanoid robots
- Geekplus’ industrial robots fail to dazzle investors
